| Code | Description | Claims | Beneficiaries | Total Paid |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
7,706 |
778 |
$856K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
4,074 |
3,202 |
$334K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
5,097 |
3,806 |
$299K |
| 80053 |
Comprehensive metabolic panel |
16,959 |
12,024 |
$230K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
15,393 |
10,355 |
$131K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
3,397 |
2,705 |
$118K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
6,915 |
4,608 |
$91K |
| 70450 |
Computed tomography, head or brain; without contrast material |
798 |
595 |
$74K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,593 |
323 |
$72K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,678 |
4,022 |
$60K |
| 71045 |
Radiologic examination, chest; single view |
4,025 |
2,770 |
$54K |
| X4011 |
State-specific procedure code |
337 |
296 |
$51K |
| A0425 |
Ground mileage, per statute mile |
987 |
681 |
$50K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
459 |
313 |
$47K |
| 85027 |
|
5,706 |
5,014 |
$46K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,866 |
2,600 |
$38K |
| 80061 |
Lipid panel |
3,775 |
3,458 |
$38K |
| 83880 |
|
2,073 |
1,438 |
$37K |
| 80050 |
General health panel |
928 |
719 |
$36K |
| 84484 |
|
3,940 |
2,228 |
$30K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
336 |
300 |
$20K |
| 81001 |
|
4,754 |
3,484 |
$19K |
| Y7506 |
|
856 |
620 |
$18K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
693 |
526 |
$17K |
| 71046 |
Radiologic examination, chest; 2 views |
913 |
742 |
$14K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
122 |
94 |
$13K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,553 |
1,377 |
$13K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
777 |
593 |
$12K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,003 |
884 |
$10K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
608 |
520 |
$9K |
| G0378 |
Hospital observation service, per hour |
63 |
38 |
$8K |
| 87088 |
|
1,296 |
907 |
$8K |
| X4006 |
|
27 |
25 |
$8K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
174 |
69 |
$8K |
| 36415 |
Collection of venous blood by venipuncture |
2,517 |
1,668 |
$7K |
| J3490 |
Unclassified drugs |
417 |
239 |
$7K |
| 87040 |
|
1,174 |
524 |
$6K |
| 86140 |
|
1,011 |
697 |
$5K |
| 82553 |
|
244 |
173 |
$5K |
| 87807 |
|
456 |
365 |
$4K |
| 83605 |
|
503 |
321 |
$3K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
816 |
598 |
$3K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
58 |
39 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
141 |
100 |
$3K |
| 83690 |
|
372 |
243 |
$2K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
61 |
42 |
$2K |
| 84146 |
|
146 |
141 |
$2K |
| 81000 |
|
675 |
598 |
$2K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
17 |
12 |
$2K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
90 |
72 |
$2K |
| 85610 |
|
627 |
413 |
$2K |
| 81003 |
|
395 |
308 |
$707.32 |
| 84703 |
|
68 |
51 |
$697.25 |
| 80306 |
|
52 |
41 |
$617.64 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
418 |
368 |
$507.54 |
| 85379 |
|
76 |
63 |
$502.85 |
| 82962 |
|
50 |
29 |
$397.45 |
| 83735 |
|
146 |
81 |
$380.62 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
15 |
12 |
$375.04 |
| 73630 |
|
16 |
12 |
$283.23 |
| 90688 |
|
22 |
20 |
$274.55 |
| 83655 |
|
12 |
12 |
$178.76 |
| 82150 |
|
18 |
12 |
$169.39 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
42 |
25 |
$153.42 |
| 85730 |
|
58 |
40 |
$114.97 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
129 |
106 |
$4.38 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
27 |
12 |
$0.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
18 |
12 |
$0.00 |